Posted by Michael Wonder on 28 Jan 2016
Neos Therapeutics announces FDA approval of Adzenys XR-ODT (amphetamine extended-release orally disintegrating tablet) for the treatment of ADHD in patients 6 years and older
27 January 2016 - With this approval, Adzenys XR-ODT is the first and only extended-release orally disintegrating tablet (ODT) for the treatment of ADHD.
For more details, go to: http://investors.neostx.com/phoenix.zhtml?c=254075&p=RssLanding&cat=news&id=2132931
